# Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

> **NCT03686696** · PHASE4 · TERMINATED · sponsor: **Uppsala University** · enrollment: 198 (actual)

## Conditions studied

- Myocardial Infarction With Non-obstructive Coronary Arteries

## Interventions

- **DRUG:** Beta blocker
- **DRUG:** ACEI
- **DRUG:** ARB

## Key facts

- **NCT ID:** NCT03686696
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-16
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-08-22
- **Target enrollment:** 198 (ACTUAL)
- **Why stopped:** Low inclusion rate.
- **Last updated:** 2023-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686696, "Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03686696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*